Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum. Supported by approximately $495 million in cash and short-term investments ...
For decades, treating depression has largely involved a difficult form of medical guesswork: prescribing one antidepressant ...
For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey.
Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...
Combinatorial optimization problems are often encountered in real-world applications, including logistics, scheduling and ...
Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...
By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than 8 million deaths around ...
In 2017, Google released a scientific paper, which spoke of an algorithm that led to the development of what is now called ...
Trions form when three particles, like quarks or electrons, come together. This formation occurs in quantum particles in ...
In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...
Earnings call Synopsys delivered Q2 FY26 results above guidance, with revenue of $2.276B (+8% YoY in EDA), non-GAAP operating margin of 39.5%, and non-GAAP EPS of $3.35. Management raised full-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results